These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A brief history of treatments for childhood acute lymphoblastic leukaemia]. Leverger G; Baruchel A; Schaison G Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630 [TBL] [Abstract][Full Text] [Related]
6. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide. Estlin EJ; Yule SM; Lowis SP Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927 [TBL] [Abstract][Full Text] [Related]
7. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97. Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE; Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530 [TBL] [Abstract][Full Text] [Related]
8. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside? Izraeli S Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159 [TBL] [Abstract][Full Text] [Related]
9. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia. Schrappe M Radiat Prot Dosimetry; 2008; 132(2):130-3. PubMed ID: 19017727 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in acute lymphoblastic leukemia in children and adolescents: an expert panel discussion. Asselin BL; Gaynon P; Whitlock JA Curr Opin Oncol; 2013 Dec; 25 Suppl 3():S1-13; quiz S14-6. PubMed ID: 24305505 [TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Cheok MH; Evans WE Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071 [TBL] [Abstract][Full Text] [Related]
13. Treatment of childhood and adult acute lymphoblastic leukaemia. Liesner R; Goldstone AH J Intern Med Suppl; 1997; 740():29-36. PubMed ID: 9350179 [TBL] [Abstract][Full Text] [Related]
14. [Prognosis prediction for childhood acute lymphoblastic leukemia--review]. Liu Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):202-6. PubMed ID: 17490555 [TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now. Goulden N; Virgo P; Grimwade D Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770 [TBL] [Abstract][Full Text] [Related]
16. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines. Ronghe M; Burke GA; Lowis SP; Estlin EJ Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926 [TBL] [Abstract][Full Text] [Related]
17. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia. Rubnitz JE J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol. Gandemer V; Pochon C; Oger E; Dalle JH; Michel G; Schmitt C; de Berranger E; Galambrun C; Cavé H; Cayuela JM; Grardel N; Macintyre E; Margueritte G; Méchinaud F; Rorhlich P; Lutz P; Demeocq F; Schneider P; Plantaz D; Poirée M; Bordigoni P Br J Haematol; 2014 May; 165(3):392-401. PubMed ID: 24479958 [TBL] [Abstract][Full Text] [Related]